Trends in the Incidence of Sudden Deaths and Heart Diseases in Fukushima After the Great East Japan Earthquake.


Journal

International heart journal
ISSN: 1349-3299
Titre abrégé: Int Heart J
Pays: Japan
ID NLM: 101244240

Informations de publication

Date de publication:
30 Nov 2019
Historique:
pubmed: 2 11 2019
medline: 18 12 2019
entrez: 1 11 2019
Statut: ppublish

Résumé

On March 11, 2011, a great earthquake, known as the Great East Japan Earthquake, hit northeastern Japan, resulting in a tsunami that caused a nuclear disaster, the Fukushima Daiichi Nuclear Power Plant accident, forcing about 160,000 people to evacuate. We, therefore, sought to examine the effects of this evacuation on the onset of cardiovascular diseases and sudden death (SD) in Fukushima Prefecture, three years after the earthquake. We divided the evacuation zone into two areas, whole evacuation zone (Area 1) and partial evacuation zone (Area 2), and we defined the north district of the prefecture as the control area (Area 3). We cross-referenced the death certificate data with data from the Fukushima Prefecture acute myocardial infarction registration survey. For each area, we tallied the number of people who fell into the SD, myocardial infarction (MI), and MI suspected groups. We calculated the age-adjusted incidence rates and analyzed the differences in the adjusted incidence rates across three years using a Poisson regression model. The age-adjusted death rate of the SD group was significantly higher in 2011 in all areas than in 2012 or 2013 (P < 0.05). The total death rate was higher in Area 1 in March 2011, just after the disaster, than in the other two areas. The rate of SD was also higher in Area 1 than in the other areas in March 2011. The incidence of sudden cardiac death might have increased just after the Great East Japan Earthquake in the evacuation area, but not in other areas in Fukushima Prefecture.

Identifiants

pubmed: 31666454
doi: 10.1536/ihj.19-110
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1253-1258

Auteurs

Mai Takiguchi (M)

Department of Cardiovascular Medicine, Fukushima Medical University School of Medicine.

Tetsuya Ohira (T)

Radiation Medical Science Center for the Fukushima Health Management Survey, Fukushima Medical University.
Department of Epidemiology, Fukushima Medical University School of Medicine.

Hironori Nakano (H)

Radiation Medical Science Center for the Fukushima Health Management Survey, Fukushima Medical University.
Department of Epidemiology, Fukushima Medical University School of Medicine.

Yui Yumiya (Y)

Radiation Medical Science Center for the Fukushima Health Management Survey, Fukushima Medical University.
Department of Epidemiology, Fukushima Medical University School of Medicine.

Takayoshi Yamaki (T)

Department of Cardiovascular Medicine, Fukushima Medical University School of Medicine.

Akiomi Yoshihisa (A)

Department of Cardiovascular Medicine, Fukushima Medical University School of Medicine.

Kazuhiko Nakazato (K)

Department of Cardiovascular Medicine, Fukushima Medical University School of Medicine.

Hitoshi Suzuki (H)

Department of Cardiovascular Medicine, Fukushima Medical University School of Medicine.

Tetsuo Ishikawa (T)

Radiation Medical Science Center for the Fukushima Health Management Survey, Fukushima Medical University.
Department of Radiation Physics and Chemistry, Fukushima Medical University School of Medicine.

Seiji Yasumura (S)

Radiation Medical Science Center for the Fukushima Health Management Survey, Fukushima Medical University.
Department of Public Health, Fukushima Medical University School of Medicine.

Kenji Kamiya (K)

Radiation Medical Science Center for the Fukushima Health Management Survey, Fukushima Medical University.
Research Institute for Radiation Biology and Medicine, Hiroshima University.

Yasuchika Takeishi (Y)

Department of Cardiovascular Medicine, Fukushima Medical University School of Medicine.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH